Approval · Notice of Compliance 33488 · 2024
ADVIL PLUS ACETAMINOPHEN: Notice of Compliance 33488
Issued June 19, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33488
- Date
- June 19, 2024
- Company
- Haleon Canada ULCMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Manufacturer Name Change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVIL PLUS ACETAMINOPHEN | 02519267 | Marketed |
Medicinal ingredients
- ACETAMINOPHEN 250 MG per TAB
- IBUPROFEN 125 MG per TAB